Guggenheim Assumes Xenon Pharmaceuticals (XENE) at Buy

October 5, 2026 4:08 PM

Guggenheim analyst Delma Caiati assumes coverage on Xenon Pharmaceuticals (NASDAQ: XENE) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found